Omicron subvariant XBB.1.5 should be the focus of Covid shots this autumn.

> XBB.1.5 strain of Covid CFOTO | Future Publishing | Getty Images The U.S. Food and Drug Administration (FDA) has released a recommendation for Covid vaccine manufacturers to develop single-strain shots for the fall that specifically target the omicron subvariant XBB.1.5. This strain is currently the dominant variant of the virus nationwide. In their official …

Read more

Democrats urge Walmart, Costco, Kroger to address concerns regarding mifepristone

House Democrats have called on major retail pharmacies, including Walmart, Costco, Kroger, Safeway, and Health Mart, to publicly commit to selling the prescription abortion pill mifepristone at their retail pharmacies. Currently, pending lawsuits have put mifepristone’s approval in the US at risk, even though it is the most common method for terminating pregnancy in the …

Read more

Continuing the Rally on Wall Street: Book Profits Wisely

Every weekday at 10:20 a.m. ET, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream. Let’s take a look at the key moments from Thursday’s session: 1. Book profits on big winners: On Thursday, Wall Street saw a significant climb, with the Dow Jones Industrial Average gaining over 350 points or roughly …

Read more

FDA advisors recommend targeting XBB variant with Covid vaccines this fall.

A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters The U.S. Food and Drug Administration’s independent panel of advisors on Thursday recommended updating Covid shots for the fall and winter to target one specific variant – the …

Read more

Ex-UK Prime Minister Boris Johnson found guilty of intentionally misleading parliament, committee declares

A parliamentary committee in the U.K. has determined that former Prime Minister Boris Johnson deliberately misled parliament regarding the illegal Covid-19 lockdown parties that occurred during his time in office. The committee’s report, known as the “partygate” report, describes this action as a “serious contempt” and states that there is no previous record of a …

Read more

UnitedHealth warns of rising healthcare expenses as health insurance stocks plummet

Health insurer stocks experienced a decline on Wednesday following a warning from UnitedHealth Group about higher medical costs. The company highlighted that older Americans are starting to catch up on surgeries they delayed during the Covid-19 pandemic (source). As a result, UnitedHealth’s shares, the largest U.S. health-care provider by market value, closed around 6% lower, …

Read more

The Arduous Road Ahead for Novavax’s Survival

In this illustration photo taken in Krakow, Poland on December 2, 2021, medical syringes and the Novavax logo are prominently displayed in the background. Novavax, a cash-strapped Covid vaccine maker, is confident about its ability to survive and thrive. The Maryland-based company recently announced its first-quarter financial results, which included a cost-cutting initiative and a …

Read more

Cramer Advises Purchasing Dip in GE Healthcare; Wishes to Follow Suit

Investment opportunity alert: Shares of GE Healthcare (GEHC) are currently experiencing a slide, providing a chance for savvy investors to take advantage of an attractive valuation in the medical-technology industry. The decline is due to its largest shareholder, General Electric (GE), monetizing its ownership stake in GEHC to pay off its own debt. However, this …

Read more

AstraZeneca and Sanofi’s Antibody for Infants with RSV Receives Approval from FDA Advisors.

An independent advisory panel to the Food and Drug Administration (FDA) has recommended the approval of nirsevimab, a monoclonal antibody developed by AstraZeneca to protect infants from respiratory syncytial virus (RSV), which is the leading cause of hospitalization among newborns. If approved, nirsevimab would be the first medical intervention available in the U.S. that can …

Read more